Lille Score (Alcoholic Hepatitis)
iatroX editorial team · Updated · Record checked · editorial policy
The Lille score assesses the response to corticosteroid treatment in severe alcoholic hepatitis at day 7. A score >0.45 identifies non-responders in whom steroids should be discontinued to avoid unnecessary infection risk.
inputs
evidence
derivation
Developed by Louvet et al. (Hepatology 2007) from a cohort of 320 patients with severe alcoholic hepatitis treated with corticosteroids.
validation
Lille >0.45 identified non-responders with 6-month survival of ~25% vs ~85% for complete responders. The STOPAH trial (Thursz/NEJM 2015) corroborated the general framework of steroid use and response assessment in alcoholic hepatitis.
guideline endorsements
EASL 2018 alcohol-related liver disease guidelines: assess steroid response at day 7 with Lille. AASLD alcoholic hepatitis guidance references Lille. BSG guidelines align.
references
- Louvet A, Naveau S, Abdelnour M, et al. The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids. Hepatology. 2007;45(6):1348-1354.PMID: 17518367
- Thursz MR, Richardson P, Allison M, et al. Prednisolone or pentoxifylline for alcoholic hepatitis. NEJM. 2015;372(17):1619-1628.PMID: 25901427
- EASL Clinical Practice Guidelines: Management of alcohol-related liver disease. J Hepatol. 2018;69(1):154-181.PMID: 29628280